Peptide-based tumor inhibitor encoding mitochondrial p14ARFis highly efficacious to diverse tumors

Cathepsin B as a cancer target

(2013) Christopher S Gondi et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers

(2013) K. Saito et al.   MOLECULAR CANCER THERAPEUTICS

Cathepsin B Degradable Star-Shaped Peptidic Macromolecules for Delivery of 2-Methoxyestradiol

(2013) Ravi Shankar et al.   MOLECULAR PHARMACEUTICS

Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

(2012) Eisaku Kondo et al.   Nature Communications

Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function

(2011) Julia Pimkina et al.   CANCER BIOLOGY & THERAPY

Amino terminal hydrophobic import signals target the p14ARF tumor suppressor to the mitochondria

(2011) Mal Irvine et al.   CELL CYCLE

The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy

(2010) Stephen J. Ralph et al.   MOLECULAR ASPECTS OF MEDICINE

ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4

(2009) Carmen Dominguez-Brauer et al.   EMBO REPORTS

p53-Dependent and p53-Independent Activation of Autophagy by ARF

(2008) W. M. Abida et al.   CANCER RESEARCH